Kestra Medical Technologies initiates coverage with an Outperform rating and $34 target price
KMTS•Evercore ISI initiated coverage of Kestra Medical Technologies with an Outperform rating and a $34 target price.
Related News
Northrop Grumman expects 2027 sales growth of 5% to 7%, with further acceleration in 2028
NOC•
Halliburton gains on Q3 profit beat
HAL•
UPM showcases starch-based paper packaging at PACK EXPO
INGR•
Chicago Atlantic Real Estate Finance updates financial calendar
REFI•
Polestar-Oxford study finds 32% higher peak acceleration in Polestar 4 Performance versus Rear motor
PSNY•